Skip to content
PfizerSTN 12 5 mg

Drawing based on the label description. No photo yet.

“Capsules, hard gelatin: 12.5 mg sunitinib: orange cap and orange body, printed with white ink "Pfizer" on the cap and "STN 12.5 mg" on the body. 25 mg sunitinib: caramel cap and orange body, printed with white ink "Pfizer" on the cap and "STN 25 mg" on the body. 37.5 mg sunitinib: yellow cap and yellow body, printed with black ink "Pfizer" on the cap and "STN 37.5 mg" on the body. 50 mg…”

Pfizer STN 12 5 mg pill

Pill with imprint Pfizer STN 12 5 mg is orange, capsule, 14 mm and has been identified as Sunitinib Malate 12.5 mg. It is used for renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors. It is supplied by Pfizer Laboratories Div Pfizer Inc.

Sunitinib Malate 12.5 mg

Imprint
Pfizer STN 12 5 mg
Strength
12.5 mg
Used for
Renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors
Color
Orange
Shape
Capsule / oblong
Size
14 mm
Score
No score line
Form
Capsule
Manufacturer
Pfizer Laboratories Div Pfizer Inc
Drug class
Cancer medicine (kinase inhibitor)
NDC
0069-0550, 0069-0550-38

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Sunitinib Malate pills and guides

What is Sunitinib Malate used for?

Sunitinib Malate is used for renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Gastrointestinal Stromal Tumor

Sunitinib malate capsules are indicated for the treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate.

Advanced Renal Cell Carcinoma

Sunitinib malate capsules are indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC).

Adjuvant Treatment of Renal Cell Carcinoma

Sunitinib malate capsules are indicated for the adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy.

Advanced Pancreatic Neuroendocrine Tumors

Sunitinib malate capsules are indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease.

From the FDA-approved label on DailyMed (published Sep 02, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows Pfizer STN 12 5 mg. The parts can be split between the two sides, so turn the pill over and check both.
  • It is orange, capsule, 14 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Sutent.

Ingredients

Active: Sunitinib Malate

Inactive: Mannitol, Croscarmellose Sodium, Povidone K25, Magnesium Stearate, Gelatin, Unspecified, Titanium Dioxide, Ferric Oxide Red, Shellac, Propylene Glycol, Sodium Hydroxide, Povidone, Unspecified, Potassium Hydroxide

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Sunitinib Malate pills